Clinical Trial Update: A Study of the Proper Dosage of Lovastatin and Docetaxel for Patients With Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the proper dosage of lovastatin and docetaxel in cancer patients; the trial has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Any Cancer
• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Lovastatin (Lovastatin)

Snippet

Sponsor: Susan L Roeder | Conditions: Any Cancer, Breast Cancer | Phase 1 | Status: TERMINATED | Results posted: 2018-10-19